Is Genprex Inc (GNPX) overvalued? · $5.3M cap
Genprex Inc (GNPX) is a biotechnology company listed on NASDAQ.
This page asks whether Genprex Inc (GNPX) looks expensive on cached numbers — not a short thesis.
Latest reported GNPX revenue for 2024-12-31 was $0. Net income was -$21.1M. GNPX currently screens at market cap $5.3M.
GNPX currently screens at market cap $5.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GNPX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GNPX stock page for the full model, not this heading.
Not investment advice.